KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.
Saved in:
| Title: | KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements. |
|---|---|
| Authors: | Au YZ; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Dana-Farber Cancer Institute, Boston, MA, USA., Gu M; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., De Braekeleer E; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Gozdecka M; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Aspris D; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Tarumoto Y; Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan., Cooper J; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Yu J; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Department of Cell Biology, The Francis Crick Institute, London, UK., Ong SH; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Chen X; Gene Expression Genomics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Tzelepis K; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge, UK., Huntly BJP; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK.; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Vassiliou G; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. gsv20@sanger.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@sanger.ac.uk., Yusa K; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK. k.yusa@infront.kyoto-u.ac.jp.; Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan. k.yusa@infront.kyoto-u.ac.jp. |
| Source: | Leukemia [Leukemia] 2021 Apr; Vol. 35 (4), pp. 1012-1022. Date of Electronic Publication: 2020 Aug 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
